Search

Search Constraints

You searched for: Author/Creator Kato, Masao

Search Results

1. A Method for Stabilizing the Proportion of the Reduced Form of Albumin During Cell‐Free and Concentrated Ascites Reinfusion Therapy in Patients with Malignant Ascites. Issue 3 (26th May 2019)

2. Comparison Between the Internal and External Pressure Filtration Method of Cell‐Free and Concentrated Ascites Reinfusion Therapy Using the Same Cancerous Ascites. Issue 3 (17th June 2019)

3. Evaluation of the performance, operability, and safety of Plasauto μ, a new type of machine for cell‐free and concentrated ascites reinfusion therapy, in a postmarketing clinical study. Issue 4 (19th May 2021)

4. First‐in‐human study of blood amyloid β removal from early Alzheimer's disease patients with normal kidney function. Issue 3 (21st March 2022)

5. Impact of low and high body mass index on predicting therapeutic efficacy and prognosis in patients with metastatic renal cell carcinoma treated with first‐line tyrosine kinase inhibitors. (30th November 2022)

6. Japanese nationwide surveillance in 2011 of antibacterial susceptibility patterns of clinical isolates from complicated urinary tract infection cases. Issue 9 (September 2015)

7. P2‐039: Evidence Supporting a Therapeutic Strategy for Alzheimer's Disease By Removal of Blood AB: Patients Who Have Undergone Hemodialysis Exhibit Lower AB Deposition in The Brain. (1st July 2016)

8. P2‐057: REMOVAL OF Aβ OLIGOMERS FROM THE BLOOD USING HOLLOW FIBERS: A POTENTIAL THERAPEUTIC SYSTEM FOR ALZHEIMER'S DISEASE. (1st July 2006)

9. P4–279: Removal of blood beta‐amyloid might reduce brain beta‐amyloid deposition based on the study of hemodialysis patients: Extracorporeal beta‐amyloid removal system (EARS) for Alzheimer's disease therapy. (1st July 2013)

10. Significance of timing of therapeutic line on effectiveness of nivolumab for metastatic renal cell carcinoma. (2nd March 2023)